A variant in orexin receptor-2 is associated with self-reported daytime sleepiness in the Japanese population

J Hum Genet. 2022 Jun;67(6):377-380. doi: 10.1038/s10038-022-01015-2. Epub 2022 Jan 17.

Abstract

Excessive daytime sleepiness is characterized by a persistent feeling of having trouble staying awake, typically with inappropriate sleep episodes. Orexin (hypocretin) is a neuropeptide that regulates sleep-wake cycles and rapid eye movement sleep. Several large-scale genome-wide association studies (GWASs) in European populations have found genetic variants in orexin receptor-1 (OX1R) and -2 (OX2R) that are associated with sleep traits including daytime sleepiness. To identify genetic variants associated with daytime sleepiness, we performed an association study of genetic variants in prepro-orexin, OX1R, and OX2R in 14,329 Japanese individuals from the Tohoku Medical Megabank Project cohort. A genetic variant in OX2R was significantly associated with self-reported daytime sleepiness after Bonferroni correction (rs188018846: P = 8.4E-05). In addition, a missense variant in OX2R identified by the European GWASs showed a nominally significant association with daytime sleepiness in a Japanese population (p.Ile308Val, rs2653349: P = 0.044). Multiple genetic variants in OX2R can affect daytime sleepiness in general populations.

MeSH terms

  • Disorders of Excessive Somnolence* / epidemiology
  • Disorders of Excessive Somnolence* / genetics
  • Genome-Wide Association Study*
  • Humans
  • Japan / epidemiology
  • Orexin Receptors / genetics
  • Orexin Receptors / metabolism*
  • Orexins / genetics
  • Self Report

Substances

  • HCRTR2 protein, human
  • Orexin Receptors
  • Orexins